Ethema Health's Revenue Soars 170% Amidst Widening Losses

TL;DR

**GRST is burning cash faster than it's growing, making its aggressive acquisition strategy a high-stakes gamble for investors.**

AI Summary

ETHEMA HEALTH Corp (GRST) reported a significant increase in revenues to $3,517,775 for the three months ended March 31, 2025, up from $1,300,100 in the prior-year period, representing a 170.57% increase. Despite this revenue growth, the company's net loss widened to $(885,097) for the quarter, compared to a net loss of $(374,203) in the same period of 2024, a 136.52% increase. This expanded loss was driven by a substantial rise in operating expenses, which climbed to $4,165,177 from $1,529,175 year-over-year, primarily due to increased salaries and wages, general and administrative costs, and rent expense. Key business changes include the January 9, 2025 acquisition of Edgewater Recovery Centers, LLC (ERC) assets by its subsidiary ARIA Kentucky LLC, and the acquisition of the remaining 25% of ATHI on May 15, 2024 for $1,100,000. The company's total liabilities surged to $36,887,448 as of March 31, 2025, from $19,616,969 at December 31, 2024, largely due to new bank loans, assumed liabilities, and related party operating lease liabilities. The strategic outlook involves continued expansion through acquisitions in the addiction treatment sector, as evidenced by the ERC and ATHI transactions.

Why It Matters

Ethema Health's substantial revenue growth, primarily driven by recent acquisitions like Edgewater Recovery Centers, LLC, signals aggressive expansion in the competitive addiction treatment market. However, the concurrent and even larger increase in net loss and total liabilities raises red flags for investors regarding profitability and financial stability. Employees might see job security in expansion but also potential pressure to improve efficiency. Customers could benefit from expanded service offerings, but the company's financial strain could impact service quality long-term. For the broader market, GRST's strategy highlights the ongoing consolidation and demand within the behavioral health sector, but also the challenges of scaling profitably.

Risk Assessment

Risk Level: high — The company's net loss increased by 136.52% to $(885,097) for the three months ended March 31, 2025, compared to $(374,203) in the prior year. Total liabilities more than doubled to $36,887,448 from $19,616,969 in just three months, indicating significant debt accumulation. The accumulated deficit also grew to $(45,304,569) as of March 31, 2025, from $(44,419,472) at December 31, 2024, demonstrating persistent unprofitability.

Analyst Insight

Investors should exercise extreme caution and consider avoiding GRST given its rapidly expanding losses and ballooning debt despite revenue growth. A deeper dive into the sustainability of its acquisition-led growth and its ability to achieve profitability is crucial before any investment consideration.

Financial Highlights

revenue

$3,517,775

total Debt

$36,887,448

net Income

$(885,097)

cash Position

$210,446

revenue Growth

+170.57%

Key Numbers

• $3,517,775 — Revenues (Increased from $1,300,100 in Q1 2024, a 170.57% increase)
• $(885,097) — Net loss (Widened from $(374,203) in Q1 2024, a 136.52% increase)
• $4,165,177 — Total operating expenses (Increased from $1,529,175 in Q1 2024)
• $36,887,448 — Total liabilities (Increased from $19,616,969 at December 31, 2024)
• $210,446 — Cash balance (Decreased from $244,771 at December 31, 2024)
• $1,100,000 — Acquisition cost of remaining 25% of ATHI (Paid on May 15, 2024)
• $250,000 — Cash paid for Edgewater Recovery Centers, LLC assets (Paid on January 9, 2025)
• 7,726,283,805 — Common shares outstanding (As of March 31, 2025)
• $(45,304,569) — Accumulated deficit (As of March 31, 2025, up from $(44,419,472) at December 31, 2024)
• $98,056 — Cash paid for interest (For the three months ended March 31, 2025, up from $3,488 in Q1 2024)

Key Players & Entities

• ETHEMA HEALTH Corp (company) — registrant
• ARIA Kentucky LLC (company) — wholly owned subsidiary of Ethema Health Corp
• Edgewater Recovery Centers, LLC (company) — acquired by ARIA Kentucky LLC
• ATHI (company) — 75% acquired by Ethema Health Corp, then remaining 25% acquired
• Shawn Leon (person) — CEO of Ethema Health Corp and controller of BH Properties Fund LLC
• BH Properties Fund LLC (company) — related party controlled by Shawn Leon, acquired real property leased to ARIA Kentucky
• Boca Cove Detox, LLC (company) — assets acquired by Ethema Health Corp subsidiary Evernia Health Center LLC
• United States government (regulator) — party to a settlement agreement assumed by ARIA Kentucky LLC
• State of Kentucky (regulator) — party to a settlement agreement assumed by ARIA Kentucky LLC
• SEC (regulator) — Securities and Exchange Commission

FAQ

Risk Factors

• Collection of Accounts Receivable [high — financial]: The company's ability to collect outstanding receivables is critical to its operations. Risks include overestimating net revenues, commercial insurance claim denials, patients failing to remit payments, and resource constraints in billing and collections. Patient non-payment of self-pay balances also poses a risk.
• Valuation of Intangible Assets in Business Combinations [medium — financial]: The company records goodwill for the excess of purchase consideration over fair value of identifiable assets and liabilities in business combinations. Valuations of intangible assets require significant estimates and assumptions regarding future cash flows, useful lives, and discount rates, which are inherently uncertain and may lead to actual results differing from estimates.

Industry Context

The addiction treatment sector is characterized by increasing demand driven by the ongoing opioid crisis and growing awareness of mental health issues. ETHEMA HEALTH is actively pursuing a growth strategy through acquisitions, aiming to consolidate its market position. However, the industry is also subject to regulatory scrutiny and reimbursement complexities from various payors.

Regulatory Implications

The company operates in a highly regulated healthcare environment. Changes in healthcare policies, reimbursement rates from government and private payors, and compliance with state and federal regulations for addiction treatment facilities are significant factors that could impact financial performance.

What Investors Should Do

1. Monitor operating expense growth relative to revenue
2. Analyze the integration and performance of acquired entities
3. Evaluate the company's debt levels and cash flow generation

Key Dates

• 2025-01-09: Acquisition of Edgewater Recovery Centers, LLC (ERC) assets — Expands the company's presence in the addiction treatment sector, contributing to revenue growth but also increasing operating expenses and liabilities.
• 2024-05-15: Acquisition of remaining 25% of ATHI — Full ownership of ATHI was secured for $1,100,000, likely aimed at consolidating operations and potentially improving profitability within that segment.

Glossary

Goodwill

An intangible asset that arises when a company acquires another company for a price greater than the fair value of its identifiable net assets. (ETHEMA HEALTH records goodwill in business combinations, such as the acquisition of ERC assets, which requires significant management estimates for valuation.)

Accumulated deficit

The cumulative net losses of a company since its inception, minus any cumulative net income. (ETHEMA HEALTH has an accumulated deficit of $(45,304,569) as of March 31, 2025, indicating a history of net losses.)

Accounts receivable

Money owed to a company by its customers for goods or services that have been delivered or used but not yet paid for. (The company's ability to collect accounts receivable is critical, with several identified risks impacting its financial health.)

Year-Over-Year Comparison

ETHEMA HEALTH Corp. has demonstrated impressive revenue growth of 170.57% year-over-year, reaching $3,517,775 in Q1 2025. However, this top-line expansion has been outpaced by a 136.52% increase in net loss to $(885,097), primarily due to a significant rise in operating expenses. Total liabilities have also nearly doubled from $19,616,969 at year-end 2024 to $36,887,448 at the end of Q1 2025, indicating increased financial leverage. The cash position has slightly decreased, underscoring the need for careful cash management amidst expansion.

Key Financial Figures

• $299,492 — sition of Aria Kentucky, net of cash of $299,492 49,492 — Deposits paid ( 24,713 )
• $1,100,000 — ority stockholder for gross proceeds of $1,100,000. The Company paid an initial deposit of
• $25,000 — The Company paid an initial deposit of $25,000 and on closing an additional $600,000.
• $600,000 — of $25,000 and on closing an additional $600,000. The Company issued a non-interest-bear
• $475,000 — ssory note for the remaining balance of $475,000, which promissory note is repayable in
• $10,000 — ry note is repayable in installments of $10,000 a month on each monthly anniversary dat
• $157,500 — n (eight installments), and payments of $157,500 on month nine and month eighteen, for a
• $240,000 — ive Agreement. The purchase price was $240,000 which was settled by a deposit of $20,0
• $20,000 — 0,000 which was settled by a deposit of $20,000 and a cash payment of $220,000 and the
• $220,000 — eposit of $20,000 and a cash payment of $220,000 and the payment to the Seller of $83,39
• $83,393 — 20,000 and the payment to the Seller of $83,393 for the assumption of the security depo
• $250,000 — t closing ARIA Kentucky paid the Seller $250,000 and assumed certain liabilities related

Filing Documents

• grst_10q.htm (10-Q) — 1154KB
• ex31.htm (EX-31.1) — 15KB
• ex32.htm (EX-32.1) — 6KB
• 0001903596-25-000484.txt ( ) — 7215KB
• grst-20250331.xsd (EX-101.SCH) — 64KB
• grst-20250331_cal.xml (EX-101.CAL) — 65KB
• grst-20250331_def.xml (EX-101.DEF) — 179KB
• grst-20250331_lab.xml (EX-101.LAB) — 429KB
• grst-20250331_pre.xml (EX-101.PRE) — 353KB
• grst_10q_htm.xml (XML) — 1409KB

- FINANCIAL INFORMATION

PART I - FINANCIAL INFORMATION Item l.

Financial Statements

Financial Statements 1 Condensed Consolidated Balance Sheets as of March 31, 2025 (Unaudited) and December 31, 2024 1 Unaudited Condensed Consolidated 2 Unaudited Condensed Consolidated 3 Unaudited Condensed Consolidated 4 Notes to the Unaudited Condensed Consolidated Financial 5 Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations 34 Item 3.

Quantitative and Qualitative Disclosures About Market

Quantitative and Qualitative Disclosures About Market Risk 37 Item 4.

Controls and Procedures

Controls and Procedures 38

- OTHER INFORMATION

PART II - OTHER INFORMATION Item 1.

Legal Proceedings

Legal Proceedings 39 Item 1A.

Risk Factors

Risk Factors 39 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 39 Item 3. Defaults Upon Senior Securities 39 Item 4. Mine Safety Disclosures 39 Item 5. Other Information 39 Item 6. Exhibits 39

SIGNATURES

SIGNATURES 40 1 ETHEMA HEALTH CORPORATION CONDENSED CONSOLIDATED BALANCE SHEETS March 31, 2025 December 31, 2024 ASSETS (unaudited) Current assets Cash $ 210,446 $ 244,771 Accounts receivable, net 1,037,640 260,841 Prepaid expenses 19,599 23,146 Other current assets 3,250 — Total current assets 1,270,935 528,758 Non-current assets Property and equipment, net 1,304,811 699,688 Intangible assets, net 3,396,008 536,971 Goodwill 3,573,396 — Right of use assets 10,948,291 9,920,592 Right of use assets – related party 7,538,237 — Deposits paid 512,106 472,393 Total non-current assets 27,272,849 11,629,644 Total assets $ 28,543,784 $ 12,158,402 LIABILITIES AND STOCKHOLDERS' DEFICIT Current liabilities Accounts payable and accrued liabilities $ 1,255,509 $ 764,255 Bank loans 226,001 — Assumed liability 686,236 — Convertible notes, net of discounts 4,032,329 3,973,245 Short-term notes, net 2,718,001 2,575,123 Promissory note 375,000 405,000 Receivables funding, net 791,686 516,247 Related party advance, net 271,579 264,966 Government assistance loans 15,216 15,088 Operating lease liability 498,381 299,102 Operating lease liability -related party 410,826 — Finance lease liability 9,156 9,829 Related party payables 1,527,467 633,318 Stock subscription liability 198,600 198,600 Total current liabilities 13,015,987 9,654,773 Non-current liabilities Bank loans 4,121,391 — Assumed liability 906,609 — Note payable – related party 83,053 — Government assistance loans 6,073 6,149 Operating lease liability 10,832,204 9,949,454 Operating lease liability – related party 7,150,459 — Finance lease liability 5,054 6,593 Deferred taxation 766,618 — Total non-current liabilities 23,871,461 9,962,196 Total liabilities 36,887,448 19,616,969 Stockholders' deficit Preferred stock - Series A; $ 0.01 par value, 10,000,

Business

Business combinations The Company allocates the fair value of purchase consideration to the tangible and intangible assets acquired and liabilities assumed for business combinations with third parties based on their estimated fair values. The excess of the fair value of purchase consideration over the fair values of these identifiable assets and liabilities is recorded as goodwill. Such valuations require management to make significant estimates and assumptions, especially with respect to intangible assets. Significant estimates in valuing certain intangible assets include, but are not limited to, future expected cash flows from acquired users, acquired technology, and trade names from a market participant perspective, useful lives and discount rates. Management's estimates of fair value are based upon assumptions believed to be reasonable, but which are inherently uncertain and unpredictable and, as a result, actual results may differ from estimates. 7 ETHEMA HEALTH CORPORATION NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS 2. Summary of significant accounting policies (continued) d) Cash and cash equivalents For purposes of the statements of cash flows, the Company considers all highly liquid instruments purchased with a maturity of three months or less and money market accounts to be cash equivalents. The Company maintains cash and cash equivalents with several financial institution in the USA and Canada. There were no cash equivalents at March 31, 2025 and December 31, 2024. The Company primarily places cash balances in the USA with high-credit quality financial institutions located in the United States which are insured by the Federal Deposit Insurance Corporation up to a limit of $ 250,000 per institution. e) Accounts receivable Accounts receivable primarily consists of amounts due from third-party payors (non-governmental) and private pay patients and is recorded net of allowances for doubtful accounts and contract

View Full Filing

View this 10-Q filing on SEC EDGAR